Table 1 Quality scoring using the CHEERS criteria
|  | CHEERS criterion | CUA of transplanting infectious kidneys (n = 03) | CUA of kidney allocation policies (n = 09) | CUA of technology used in KT (n = 04) | Total (%) (n = 16) |
|---|---|---|---|---|---|
1 | Title | 1 | 4 | 3 | 8 (50.0) |
2 | Abstract | 1 | 5 | 3 | 9 (56.3) |
3 | Background and objectives | 3 | 9 | 4 | 16 (100.0) |
4 | Target population and subgroups | 3 | 9 | 4 | 16 (100.0) |
5 | Setting and location | 2 | 9 | 3 | 14 (87.5) |
6 | Study perspective | 2 | 8 | 4 | 14 (87.5) |
7 | Comparators | 3 | 9 | 4 | 16 (100.0) |
8 | Time horizon | 3 | 7 | 4 | 14 (87.5) |
9 | Discount rate | 3 | 9 | 4 | 16 (100.0) |
10 | Choice of health outcomes | 3 | 9 | 2 | 14 (87.5) |
11 | Measurement of effectiveness | 2 | 9 | 4 | 15 (93.8) |
12 | Measurement and valuation of preference-based outcomes | NA | 1a | NA | 01 (100.0) |
13 | Estimating resources and costs | 1 | 9 | 4 | 14 (87.5) |
14 | Currency, price date, and conversion | 2 | 8 | 4 | 14 (87.5) |
15 | Choice of model | 2 | 7 | 3 | 12 (75.0) |
16 | Assumptions | 3 | 5 | 2 | 10 (62.5) |
17 | Analytical methods | 0 | 5 | 0 | 05 (31.3) |
18 | Study parameters | 2 | 6 | 4 | 12 (75.0) |
19 | Incremental costs and outcomes | 3 | 8 | 3 | 14 (87.5) |
20 | Characterising uncertainty | 3 | 8 | 4 | 15 (93.8) |
21 | Characterising heterogeneity | 0 | 2 | 0 | 02 (12.5) |
22 | Study findings, limitations, generalisability, and current knowledge | 2 | 7 | 4 | 13 (81.3) |
23 | Source of funding | 1 | 7 | 2 | 10 (62.5) |
24 | Conflicts of interest | 1 | 5 | 2 | 08 (50.0) |